期刊文献+

丹参酮ⅡA纳米粒治疗小鼠肝癌及其对Cyclin E表达的影响 被引量:16

Effects of TanshinoneⅡA Nanoparticles on Hepatoma and Cyclin E Expression in Mice
下载PDF
导出
摘要 目的探讨丹参酮ⅡA纳米微粒(tanshinoneⅡA nanoparticle,TS-NP)治疗小鼠肝癌的作用及机制。方法采用乳化溶剂挥发法(O/W)制备TS-NP。建立小鼠肝癌模型,随机分为生理盐水组、空白纳米组(blank nanoparticle,B-NP)、丹参酮ⅡA组(tanshinoneⅡA,TSⅡA)和TS-NP低、中、高3个剂量组(TS-NP L、TS-NP M、TS-NP H),分别尾静脉给药。治疗第8天处死小鼠,比较各组肿瘤重量、肿瘤坏死程度。采用TUNEL标记法检测细胞凋亡率,免疫组化S-P法检测周期蛋白E(Cyclin E)的表达。结果治疗后与生理盐水组比较,TSⅡA组、TS-NP各剂量组瘤体重量显著降低(P<0.01)TS-NP组瘤体重量明显低于等剂量的TSⅡA组(P<0.01),肿瘤坏死明显(P<0.01),肝癌细胞凋亡率升高(P<0.01),Cyclin E的表达降低(P<0.01)。结论TS-NP能够抑制小鼠肝癌生长,丹参酮ⅡA纳米的疗效优于等剂量的丹参酮ⅡA;其治疗肝癌的机制可能与抑制Cyclin E表达从而抑制肿瘤细胞增殖、诱导细胞调亡有关。 Objective To investigate the mechanism of Tanshinone Ⅱ A nanoparticles (TS-NP)-induced apoptosis on hepatoma in mice. Methods TS-NP was prepared with O/W, hepatoma model in mice was established. Mice with hepatoma were randomly divided into six groups: control group (NS), blank nanoparticles (B-NP) group, Tanshinone Ⅱ A nanoparticles low dose (TS-NP L) group, middle dose(TS-NP M) group, high dose (TS-NP H) group. Separately NS, B-NP, TS Ⅱ A, TS-NP L, TS-NP M, TS-NP H were infused via tail vein. On the 8th day after treatment, and the mice were sacrificed. The weight and necrosis grade of tumor in each group were compared. The cell apoptosis index was tested by TUNEL; and the expression of Cyclin E was detected by immunohistochemical technique (S-P method). Results The weight of TS Ⅱ A and TS-NP group was significantly lower than that of NS group (P〈0.01) and tumor necrosis was more serious. The apopoptic index in TS Ⅱ A and TS-NP group was higher than those of other groups (P〈0.01), but the expression of Cyclin E was lower (P〈0.01). Conclusion TS-NP can inhibit the growth of tumor in mice; and the curative effect of Tanshinone Ⅱ A nanoparticles was better than that of Tanshinone Ⅱ A with the same dose. The mechanism of TS-NP on hepatoma may be associated with decreased expression of Cyclin E to inhibit the cell proliferation and promote the apoptosis.
出处 《上海中医药杂志》 北大核心 2007年第9期74-77,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 上海市中医药科研基金资助项目(2004J012A) 上海市医学重点专科建设项目(05Ⅱ016)
关键词 纳米 丹参酮ⅡA 肝癌 细胞凋亡 周期蛋白E Nanoparticles Tanshinone Ⅱ A hepatoma apoptosis Cyclin E
  • 引文网络
  • 相关文献

参考文献9

二级参考文献64

  • 1李承珠,杨诗春,赵风娣,黄春妹.活血化瘀中药丹参对大鼠Walker256癌细胞血行播散的影响[J].肿瘤,1983(2):66-66. 被引量:1
  • 2李锦毅,李德新.中药诱导肝癌小鼠细胞凋亡作用及细胞周期变化的实验研究[J].中国中医基础医学杂志,2002,8(4):29-30. 被引量:7
  • 3郑占虎 董泽宏 等.中药现代研究与应用[M].北京:学苑出版社,1998,1,1998,2,1998,3,1998,4.415,612,2000,1149,2319,3101,3202.
  • 4Chang W L, Chen C F. Cytotoxic, activity of tanshimme against human carcinoma cell lines[J]. Am J Chin Med, 1991,19(3) :207 - 212.
  • 5Kerr J E R, Wyllie A H, Currie A H, et al. Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics [ J ]. Br J Cancer,.1972,26(4) :239 - 257.
  • 6Thompson C B. Apoptosis in the pathogenesis and treatment of disease [J].Science, 1995,267(5203) : 1456-1462.
  • 7Ridge JA, Collin C, Bading JR, Hancock C, Conti PS, Daly JM,Raaf JH. Increased adriamycin levels in hepatic implants of rabbits Vx-2 carcinoma from regional infusion. Cancer Res 1988; 48:4584-4587.
  • 8Eksborg S, Cedermark BJ, Strandler HS. Intrahepatic and intravenous administration of adriamycin - a comparative pharmacokinetics study in patients with malignant liver tumours. Med Oncol Tumor Pharmacother 1985; 2:47-54.
  • 9Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet JP,Couvreur P. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. adm/nistration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol 1990; 26:122-126.
  • 10Andrieu V, Fessi H, Dubrasquet M, Devissaguet JP, Puisieux F,Benita S. Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Des Deliv 1989; 4:295-302.

共引文献420

同被引文献250

引证文献16

二级引证文献73

;
使用帮助 返回顶部